RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Dr. Holly Peay

Holly Landrum Peay

Senior Research Scientist


PhD, Medicine (Social Science), Leiden University
MS, Genetic Counseling, University of South Carolina School of Medicine
BA, Interdisciplinary Studies in Biomedical Ethics, University of Virginia

Dr. Peay is the Director of the Early Check newborn screening study in North Carolina. In addition, Dr. Peay leads research funded by the Food and Drug Administration, National Institutes of Health, not-for-profit foundations, and patient advocacy organizations.

Dr. Peay conducts research related to common and rare disorders with a focus on genetic disorders, newborn screening, and gene therapy/gene editing. Dr. Peay’s research explores the impact and ethical use of emerging technologies such as genome sequencing, ethical considerations related to clinical trials, patient preference and experience, disclosure of research results to participants, and decision support and informed consent tools. Dr. Peay frequently conducts community-engaged research in which she ensures diverse perspectives are included in study planning, implementation, reporting, and the development of recommendations or guidance.

Dr. Peay is Board Certified in genetic counseling by the American Board of Genetic Counseling.


Get in Touch

To speak to this expert or inquire about RTI services, you can reach us at +1 919 541 6000 or use the contact form below. For media inquiries, please reach out to our Media Relations team at news@rti.org.

Blue background circle graphics